These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Recent development of IMP dehydrogenase inhibitors for the treatment of cancer. Chen L; Pankiewicz KW Curr Opin Drug Discov Devel; 2007 Jul; 10(4):403-12. PubMed ID: 17659481 [TBL] [Abstract][Full Text] [Related]
16. Drug evaluation: MGCD-0103, a histone deacetylase inhibitor for the treatment of cancer. Kell J Curr Opin Investig Drugs; 2007 Jun; 8(6):485-92. PubMed ID: 17621879 [TBL] [Abstract][Full Text] [Related]
19. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies. Wright DG; Boosalis M; Malek K; Waraska K Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336 [TBL] [Abstract][Full Text] [Related]